HEALTHEQUITY ($HQY) is expected to release its quarterly earnings data on Tuesday, September 2nd after market close, per Finnhub. Analysts are expecting revenue of $324,029,987 and earnings of $0.94 per share.
You can see Quiver Quantitative's $HQY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HEALTHEQUITY Insider Trading Activity
HEALTHEQUITY insiders have traded $HQY stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $HQY stock by insiders over the last 6 months:
- JON KESSLER has made 0 purchases and 9 sales selling 231,950 shares for an estimated $25,992,976.
- ELIMELECH ROSNER (EVP, CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 2 sales selling 71,000 shares for an estimated $7,976,299.
- MICHAEL HENRY FIORE (EVP, CHIEF COMMERCIAL OFFICER) has made 0 purchases and 3 sales selling 10,675 shares for an estimated $877,544.
- ROBERT W SELANDER has made 0 purchases and 3 sales selling 5,750 shares for an estimated $446,512.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HEALTHEQUITY Hedge Fund Activity
We have seen 249 institutional investors add shares of HEALTHEQUITY stock to their portfolio, and 271 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WEALTHFRONT ADVISERS LLC removed 107,390,188 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,490,070,913
- WASATCH ADVISORS LP removed 1,132,972 shares (-15.7%) from their portfolio in Q2 2025, for an estimated $118,690,146
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 835,413 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $87,517,865
- CITADEL ADVISORS LLC added 777,148 shares (+179.4%) to their portfolio in Q2 2025, for an estimated $81,414,024
- WESTFIELD CAPITAL MANAGEMENT CO LP added 701,819 shares (+124.6%) to their portfolio in Q2 2025, for an estimated $73,522,558
- ATALAN CAPITAL PARTNERS, LP added 700,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $73,332,000
- AQR CAPITAL MANAGEMENT LLC added 661,795 shares (+148.5%) to their portfolio in Q2 2025, for an estimated $69,329,644
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HEALTHEQUITY Government Contracts
We have seen $20,771,833 of award payments to $HQY over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THIS TASK ORDER IS ISSUED TO OFFSET (BUYDOWN) PART OF THE ADMINISTRATIVE FEE CHARGED TO AGENCIES FOR BENEFI...: $13,300,656
- FSA FEDS TASK ORDER FY25: $2,780,980
- DEPARTMENT OF THE NAVY HC/DC FEDERAL FLEXIBLE SPENDING ACCOUNTS FY25: $555,812
- ARMY FLEXIBLE SPENDING ACCOUNTING FOR FY2025: $451,492
- FSAFEDS ADMINISTRATIVE ACCOUNT FEES FOR DOJ: $416,935
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
HEALTHEQUITY Congressional Stock Trading
Members of Congress have traded $HQY stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HQY stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 06/17.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HEALTHEQUITY Analyst Ratings
Wall Street analysts have issued reports on $HQY in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 08/29/2025
- RBC Capital issued a "Outperform" rating on 08/28/2025
- Deutsche Bank issued a "Buy" rating on 06/05/2025
- B of A Securities issued a "Buy" rating on 06/04/2025
- JMP Securities issued a "Market Outperform" rating on 06/04/2025
- Keybanc issued a "Overweight" rating on 04/16/2025
- Raymond James issued a "Strong Buy" rating on 03/25/2025
To track analyst ratings and price targets for HEALTHEQUITY, check out Quiver Quantitative's $HQY forecast page.
HEALTHEQUITY Price Targets
Multiple analysts have issued price targets for $HQY recently. We have seen 9 analysts offer price targets for $HQY in the last 6 months, with a median target of $117.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $125.0 on 08/29/2025
- Daniel R. Perlin from RBC Capital set a target price of $109.0 on 08/28/2025
- C. Gregory Peters from Raymond James set a target price of $120.0 on 07/08/2025
- George Hill from Deutsche Bank set a target price of $115.0 on 06/05/2025
- Constantine Davides from JMP Securities set a target price of $117.0 on 06/04/2025
- Allen Lutz from B of A Securities set a target price of $125.0 on 06/04/2025
- David Roman from Goldman Sachs set a target price of $104.0 on 06/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
